Predicting Immune Pathology after Hematopoietic Stem Cell Transplant (HCT) with Day 100 Transcriptomics: Naïve CD4 T Cell Expansion Versus Regulatory Programming Predicts Patients Who Develop De Novo Chronic Gvhd (CGVHD) Versus Those Displaying Operational Immune Tolerance

Category Primary study
JournalTransplantation and Cellular Therapy
Year 2021
This article has no abstract
Epistemonikos ID: ff559e8ecc1800062316b70878cce1dcb64ee712
First added on: Feb 14, 2025